QuantX Biosciences News and Activities

Acquisition, funding and merger involving QuantX Biosciences.

• QuantX Biosciences has just announced a $85 Million fundraising (posted on February 9 2026).

View the org chart displaying its 13 main executives

Most searched biographies at QuantX Biosciences

• Wei Li, Interim Chief Executive Officer
• Judith Li, Director
• Christopher Gagliardi, Director

Create your alert
to follow the executive moves at QuantX Biosciences.

QuantX Biosciences has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by QuantX Biosciences

Social media about QuantX Biosciences

• QuantX Biosciences on Wikipedia, Google News & Yahoo Finance
• QuantX Biosciences on LinkedIn, X (Twitter) & YouTube